From Silicon to Solutions: The Role of Chiptech in Modern Medicine

The rapid advancement of chip technology has revolutionized various sectors, with modern medicine being one of the most significantly impacted. This session will explore the transformative effects of Chiptech on healthcare delivery, diagnostics, and treatment. Attendees will gain insights into how cutting-edge semiconductor innovations are enabling the development of more precise diagnostic tools, personalized medicine, and advanced therapeutic solutions. The session will feature leading experts in the field who will discuss the latest breakthroughs, current applications, and future potential of Chiptech in medicine. By delving into case studies and real-world applications, participants will learn how these technologies are improving patient outcomes and shaping the future of healthcare.

General information

Time: 11.00 - 12.00
Language: English
Room: MAIN STAGE (TL 2275 | First floor)
Available seats: 250

The programme

11.00 - 11.05	Welcome & Opening Twan Korthorst, New Origin
11.05 - 11.15	Talk 1 Anna Nikiel, Teledyne Healthcare
11.15 - 11.25	Talk 2 Martin Bennink, Saxion University of Applied Science
11.25 - 11.35	Talk 3 Albert van den Berg, University of twente
11.35 - 11.55	Panel discussion with all speakers moderated by Twan Korthorst, New Origin
11.55 - 12.00	Closing words

Speakers

Albert van den Berg | University of Twente

Prof. Dr. Ir. Albert van den Berg received his MSc and PhD from the University of Twente. He worked on miniaturized chemical sensors in Switzerland and became a full professor in 2000 at the MESA+ Institute for Nanotechnology. He co-founded the MicroTAS conference series and has published over 500 peer-reviewed articles, leading to more than 10 spin-off companies. His awards include multiple ERC grants and membership in the Royal Dutch Academy of Sciences. He was the scientific director of the MIRA Institute (2014-2018) and is currently focused on micro/nanofluidics, health sustainability, and organs-on-chip.

Anna Nikiel | Teledyne Healthcare

Anna Nikiel is a professional at Teledyne DALSA, part of the global Teledyne Imaging Group, specializing in technologies for sensing, signaling, and processing. Since January 2022, she has focused on outreach to sectors such as THz, integrated photonics, advanced semiconductors, and quantum technologies, with an emphasis on innovating breast cancer screening.

A graduate of Uniwersytet Jagielloński w Krakowie, Anna values Teledyne's commitment to environmental sustainability and global citizenship. She thrives in collaborative environments that encourage system-level thinking and deep-tech innovations. Inspired by her colleagues at the High Tech Campus Eindhoven, she is dedicated to exploring new challenges and advancing technology.

Martin Bennink | Saxion University of Applied Sciences

Martin Bennink (1973) studied Applied Physics at the University of Twente, graduating in 1996 with a thesis on cell flow cytometry for rapid white blood cell characterization. He completed his PhD in 2001 under Professors Jan Greve and Bart de Grooth, focusing on developing optical tweezers to manipulate biomolecules.

After a brief postdoctoral period, Martin coordinated the Nano Link program at the MESA+ Institute for Nanotechnology in 2002 and later contributed to bionanotechnology research. In 2009, he became an assistant professor in nanobiophysics at the University of Twente, where he investigates the mechanical properties of biomaterials.

Passionate about education, Martin initiated the Master Course in Nanotechnology in 2003 and established workshops for PhD and MSc students, incorporating innovative teaching methods like blended learning and MOOCs.

Back to session overview